Anticancer activity and radiosensitization effect of methyleneisoxazolidin-5-ones in hepatocellular carcinoma HepG2 cells

被引:4
|
作者
Gach, Katarzyna [1 ]
Gradzka, Iwona [2 ]
Wasyk, Iwona [2 ]
Meczynska-Wielgosz, Sylwia [2 ]
Iwanenko, Teresa [2 ]
Szymanski, Jacek [3 ]
Koszuk, Jacek [4 ]
Janecki, Tomasz [4 ]
Kruszewski, Marcin [2 ,5 ]
Janecka, Anna [1 ]
机构
[1] Med Univ Lodz, Fac Med, Dept Biomol Chem, PL-92215 Lodz, Poland
[2] Inst Nucl Chem & Technol, Ctr Radiobiol & Biol Dosimetry, PL-03195 Warsaw, Poland
[3] Med Univ Lodz, Fac Hlth Sci, Cent Sci Lab, Div Publ Hlth, PL-92215 Lodz, Poland
[4] Lodz Univ Technol, Inst Organ Chem, Lodz, Poland
[5] Univ Informat Technol & Management, Fac Med, Rzeszow, Poland
关键词
Anticancer agents; Apoptosis; HepG2; Integrated therapy; X-ray sensitization; NF-KAPPA-B; CANCER CELLS; RADIATION-THERAPY; INDUCED APOPTOSIS; COMET ASSAY; DNA-DAMAGE; PARTHENOLIDE; INHIBITION; 4-METHYLIDENEISOXAZOLIDIN-5-ONES; PROLIFERATION;
D O I
10.1016/j.cbi.2016.01.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parthenolide (PTL), a well-known sesquiterpene lactone of natural origin with alpha, beta-unsaturated carbonyl structure, has proven to show promising anti-cancer properties. In this report, anti-proliferative potential of two synthetic methyleneisoxazolidin-5-ones, MZ-6 and MZ-14, with the same structural motif, has been investigated in human hepatoma HepG2 cells. The effects on apoptosis induction and DNA damage were evaluated. All compounds decreased the number of live cells and increased the number of late apoptotic cells. However, only MZ-14 was able to induce DNA damage. Both synthetic compounds increased intracellular reactive oxygen species (ROS) generation and mitochondrial membrane potential changes at the same level as PTL. Additionally, cell survival was analyzed after a combined treatment, in which HepG2 cells were preincubated for 24 h with MZ-6, MZ-14 or PTL and irradiated with different doses of X-rays. The inhibition of cell survival was assessed by the clonogenic assay. We have shown that the clone formation was strongly inhibited by the combined treatment. The synergistic effect was observed for all three compounds but MZ-6 was significantly more effective. It is interesting to note that in HepG2 cells MZ-6 was the least cytotoxic of the tested compounds, did not induce DNA damage and was less active than the others in the clonogenic cell survival assay. It seems advantages from the point of view of the further in vivo studies that the compound with the lowest cytotoxic activity showed the strongest sensitizing effect. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [31] The layered double hydroxide (LDH) nanosheets decrease anticancer potential of Satureja khuzestanica in HepG2 hepatocellular carcinoma cells
    Maleki, Milad Panahzadeh
    Soltanzade, Hossein
    Tanomand, Asghar
    Shahsavari, Gholamreza
    GENE REPORTS, 2021, 25
  • [32] CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells
    Wang, Haibo
    Qian, Zhengyao
    Zhao, Hui
    Zhang, Xibo
    Che, Shuqiang
    Zhang, Hongtao
    Shang, Haitao
    Bao, Jianheng
    Hao, Chengfei
    Liu, Junjian
    Li, Zhonglian
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 3902 - 3908
  • [33] Effects of Shikoni, 5-fluorouracil and cisplatin on APRIL expression in hepatocellular carcinoma HepG2 cells
    Guo, Y. W.
    Zheng, F. P.
    Li, Y. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A158 - A158
  • [34] Effect of a vaccine prepared by fusion of HEPG2 cells with dendritic cells from patients with hepatocellular carcinoma in vitro
    Zhang, H. M.
    Zhang, L. W.
    Liu, W. C.
    Si, X. M.
    Cheng, J.
    CYTOTHERAPY, 2006, 8
  • [35] Biochemical Effects of Silver Nanomaterials in Human Hepatocellular Carcinoma (HepG2) Cells
    Kitchin, Kirk T.
    Richards, Judy A.
    Robinette, Brian L.
    Wallace, Kathleen A.
    Coates, Najwa H.
    Castellon, Benjamin T.
    Grulke, Eric A.
    Kou, Jiahui
    Varma, Rajender S.
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2020, 20 (09) : 5833 - 5858
  • [36] Biochemical effects of copper nanomaterials in human hepatocellular carcinoma (HepG2) cells
    Kitchin, Kirk T.
    Richards, Judy A.
    Robinette, Brian L.
    Wallace, Kathleen A.
    Coates, Najwa H.
    Castellon, Benjamin T.
    Grulke, Eric A.
    CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (05) : 2311 - 2329
  • [37] Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells
    Abdallah, Fatma M.
    Helmy, Maged W.
    Katary, Mohamed A.
    Ghoneim, Asser I.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 (12) : 1399 - 1410
  • [38] ANALYSIS OF GLUCOCORTICOID RECEPTORS IN HUMAN HEPATOCELLULAR-CARCINOMA AND HEPG2 CELLS
    LUI, WY
    PENG, FK
    CHANG, YF
    CHANG, TJ
    TSAI, TF
    HSU, ML
    SU, TS
    TSAY, SH
    WU, CW
    LIU, TY
    CHI, CW
    HEPATOLOGY, 1993, 18 (05) : 1167 - 1174
  • [39] Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells
    Badroon, Nassrin A.
    Abdul Majid, Nazia
    Alshawsh, Mohammed A.
    NUTRIENTS, 2020, 12 (06) : 1 - 20
  • [40] Regulation of alternative SRC promoter usage in HepG2 hepatocellular carcinoma cells
    Dehm, SM
    Bonham, K
    GENE, 2004, 337 : 141 - 150